{{Rsnum
|rsid=7322722
|Gene=MYCBP2
|Chromosome=13
|position=77305241
|Orientation=plus
|GMAF=0.1791
|Gene_s=MYCBP2
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 3.5 | 27.4 | 69.0
| HCB | 10.2 | 39.4 | 50.4
| JPT | 12.4 | 41.6 | 46.0
| YRI | 0.0 | 16.3 | 83.7
| ASW | 0.0 | 17.5 | 82.5
| CHB | 10.2 | 39.4 | 50.4
| CHD | 8.3 | 45.0 | 46.8
| GIH | 16.8 | 55.4 | 27.7
| LWK | 3.6 | 15.5 | 80.9
| MEX | 0.0 | 10.3 | 89.7
| MKK | 1.9 | 26.9 | 71.2
| TSI | 2.9 | 25.5 | 71.6
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23551011
  |Trait=Preeclampsia
  |Title=Genome-Wide Association Study of Pre-Eclampsia Detects Novel Maternal Single Nucleotide Polymorphisms and Copy-Number Variants in Subsets of the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study Cohort.
  |RiskAllele=
  |Pval=1E-6
  |OR=2.93
  |ORtxt=[1.90-4.52]
  }}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}